(Q31886491)

4 July 2017

title

Effects of probucol on rat carotid artery responses to balloon catheter injury (English)

1 reference

4 July 2017

0 references

Jackson CL

1

1 reference

4 July 2017

Pettersson KS

series ordinal

2

1 reference

4 July 2017

publication date

1 February 2001

1 reference

4 July 2017

1 reference

4 July 2017

volume

154

1 reference

4 July 2017

issue

2

1 reference

4 July 2017

page(s)

407-414

1 reference

Animal models of restenosis

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Restenosis after coronary angioplasty: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Pharmacology of smooth muscle cell replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effect of high dose verapamil on restenosis after peripheral angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Probucol inhibits neointimal formation in carotid arteries of normocholesterolemic rabbits and the proliferation of cultured rabbit vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: possible role of PDGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Inhibitory effect of a single local probucol administration on neointimal formation in balloon-injured rat carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effects of diltiazem on complications and restenosis after coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Heparin regulates smooth muscle S phase entry in the injured rat carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Effect of ramipril, an inhibitor of angiotensin converting enzyme, on the response of rat thoracic aorta to injury with a balloon catheter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

The role of plasminogen activation in smooth muscle cell migration after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900516-5

10.1016/S0021-9150(00)00516-5

7 January 2021

Identifiers

DOI

1 reference

4 July 2017

1 reference